For most of the 2000s, workplace wellness was sold as a way to bend the claims cost curve. A 2010 Harvard Business Review article made the bullish case, using Johnson & Johnson’s program as its example, and wellness moved from benefits perk to strategic pillar.
Then the evidence arrived. RAND Health’s 2013 report, sponsored by the Labor Department and HHS, found no statistically significant savings in any year of a five-year analysis — and noted it could not assess the cost of operating the programs it studied, which makes any definitive ROI conclusion premature.
The recalibration since has been incomplete. Engagement replaced savings as the headline metric, but the 2020 randomized trial in JAMA Internal Medicine found that engaged employees showed no significant improvement in clinical outcomes. Research cited by SHRM found that 40% of implemented programs produced no discernible impact at all, while the 60% that did produced strong ones — which moves the question from whether wellness works to which programs do.
This whitepaper argues the difference is personalization: using individual health status, behavioral patterns and goals to direct the right intervention to the right person, rather than offering identical programming to everyone and measuring who signed up.
Inside:
- How the ROI case was built, and which studies dismantled it
- Why 40% of implemented programs showed no discernible impact
- The value-on-investment dimensions that replaced single-metric ROI
- What one employer’s high-risk workforce recorded over a three-year partnership